(Q40428048)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

lung small cell carcinoma

11 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

10

Alex A Adjei

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

12

James R Jett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Philip J Stella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Burke J Brooks

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Sumithra Mandrekar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

James A Bonner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

William L McGinnis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

James A Mailliard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

James E Krook

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Richard L Deming

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Aminah Jatoi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

2349-2354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15852407%20AND%20SRC:MED&resulttype=core&format=json

Nonparametric Estimation from Incomplete Observations

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Influence of age on the treatment of limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021

Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21034

7 January 2021